Efficacy Evidence Opens Door To Sell More Doctors On Joint Health Supplements
This article was originally published in The Tan Sheet
Executive Summary
Some doctors need more than impressive study results to change their routines, says Nicholas DiNubile, an orthopedic surgeon and a proponent of chondroitin/glucosamine supplementation for osteoarthritis patients. The patients, he says, often are asking about options to treatment with NSAIDs.
You may also be interested in...
Study Makes MOVES For Chondroitin/Glucosamine On Osteoarthritis Pain
At six months, 79.7% of the moderate-to-severe patients in the supplementation group and 79.2% in the celecoxib group fulfilled pain reduction criteria, the primary outcome measured in the Multicenter Osteoarthritis InterVEntion trial with SYSADOA.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.
Australian Teeth Whitener Marketer Frowns On Industry Self-Regulation Referencing US Laws
HiSmile appeals NAD recommendation following review on P&G challenge to discontinue ad claims on its website and in social media videos stating peroxide-containing whitening products are “painful” or cause pain, break down and impact gums and teeth, or “damage” gums.